Skip to content

QUALIAS: what changed

What changed

QUALIAS

BE 0462.424.833
NACE 46.460, Wholesale of pharmaceutical and medical goods
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€27,971
2024 · -€360,706+€388,677
Equity
€101,355
2024 · €73,384+€27,971
Cash
€174,950
2024 · €8,670+€166,280
Balance sheet total
€607,833
2024 · €1.0m-€400,044

Largest movements

2024 to 2025
Assets
  • Financial fixed assets -€500,000

    down €500,000 (-100.0%), from €500,205 to €205

  • Cash +€166,280

    up €166,280 (+1,918%), from €8,670 to €174,950

    mainly Investment in fixed assets (net) (+€370,932) and Receivables within one year (+€122,285)

  • Receivables within one year -€122,285

    down €122,285 (-44.1%), from €277,606 to €155,320

    of which Other amounts receivable: -€100,398

  • Intangible fixed assets +€61,260

    up €61,260 (+37.5%), from €163,302 to €224,563

Equity and liabilities
  • Debts after one year -€500,000

    down €500,000 (-62.5%), from €800,000 to €300,000

  • Tax, wage and social debts +€44,297

    up €44,297 (+148%), from €29,977 to €74,274

    of which Remuneration and social security: +€25,554

  • Accrued charges and deferred income +€30,000

    new in 2025: €30,000

  • Profit (loss) carried forward +€27,971

    up €27,971 (+6.6%), from -€423,164 to -€395,193

Income statement
  • Financial income +€486,325

    up €486,325 (+2,711%), from €17,939 to €504,265

    of which Non-recurring financial income: +€500,000

  • Gross operating margin +€246,637

    up €246,637 (+429%), from €57,543 to €304,181

  • Staff costs +€163,395

    up €163,395 (+618%), from €26,456 to €189,851

  • Financial charges +€146,971

    up €146,971 (+41.5%), from €354,478 to €501,449

    of which Non-recurring financial charges: +€150,000

  • Depreciation +€18,620

    up €18,620 (+38.9%), from €47,917 to €66,537

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€360,706
Gross operating margin +€246,637
Staff costs -€163,395
Depreciation -€18,620
Write-downs -€17,060
Other operating charges -€3,415
Financial income +€486,325
Financial charges -€146,971
Taxes +€5,176
Result 2025 €27,971
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€292,971
Investment +€373,309
Financing -€500,000
Cash 2024 €8,670
Net result for the year +€27,971
Depreciation +€66,537
Stocks and contracts +€5,062
Receivables within one year +€122,285
Smaller working-capital items -€1,861
Trade debts -€1,320
Tax, wage and social debts +€44,297
Accrued charges and deferred income +€30,000
Investment in fixed assets (net) +€370,932
Current investments +€2,377
Debts after one year -€500,000
Cash 2025 €174,950
brings cash intakes cash out
Every line side by side 51 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,007,877 €607,833 -€400,044 -39.7%
Fixed assets 21/28 €664,590 €227,121 -€437,468 -65.8%
Intangible fixed assets 21 €163,302 €224,563 +€61,260 +37.5%
Tangible fixed assets 22/27 €1,082 €2,353 +€1,271 +117%
Furniture and vehicles 24 €1,082 €115 -€967 -89.4%
Other tangible fixed assets 26 - €2,239 +€2,239
Financial fixed assets 28 €500,205 €205 -€500,000 -100.0%
Current assets 29/58 €343,287 €380,711 +€37,424 +10.9%
Stocks and contracts in progress 3 €53,076 €48,013 -€5,062 -9.5%
Stocks 30/36 €53,076 €48,013 -€5,062 -9.5%
Amounts receivable within one year 40/41 €277,606 €155,320 -€122,285 -44.1%
Trade receivables 40 €177,193 €155,305 -€21,888 -12.4%
Other amounts receivable 41 €100,413 €16 -€100,398 -100.0%
Current investments 50/53 €3,936 €1,559 -€2,377 -60.4%
Cash at bank and in hand 54/58 €8,670 €174,950 +€166,280 +1,918%
Deferred charges and accrued income 490/1 - €869 +€869
Total equity and liabilities 10/49 €1,007,877 €607,833 -€400,044 -39.7%
Equity 10/15 €73,384 €101,355 +€27,971 +38.1%
Contributions 10/11 €475,169 €475,169 = 0.0%
Reserves 13 €21,379 €21,379 = 0.0%
Non-distributable reserves 130/1 €2,629 €2,629 = 0.0%
Reserves not available under the articles 1311 €2,629 €2,629 = 0.0%
Distributable reserves 133 €18,750 €18,750 = 0.0%
Profit (loss) carried forward 14 -€423,164 -€395,193 +€27,971 +6.6%
Amounts payable 17/49 €934,493 €506,478 -€428,015 -45.8%
Amounts payable after more than one year 17 €800,000 €300,000 -€500,000 -62.5%
Other amounts payable 178/9 €800,000 €300,000 -€500,000 -62.5%
Amounts payable within one year 42/48 €134,493 €176,478 +€41,985 +31.2%
Trade debts 44 €103,524 €102,204 -€1,320 -1.3%
Suppliers 440/4 €103,524 €102,204 -€1,320 -1.3%
Taxes, remuneration and social security 45 €29,977 €74,274 +€44,297 +148%
Taxes 450/3 €25,425 €44,169 +€18,744 +73.7%
Remuneration and social security 454/9 €4,552 €30,106 +€25,554 +561%
Other amounts payable 47/48 €993 - -€993
Accrued charges and deferred income 492/3 - €30,000 +€30,000
Remuneration, social security and pensions 62 €26,456 €189,851 +€163,395 +618%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €47,917 €66,537 +€18,620 +38.9%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - €17,060 +€17,060
Other operating charges 640/8 €1,948 €5,363 +€3,415 +175%
Gross operating margin 9900 €57,543 €304,181 +€246,637 +429%
Operating profit (loss) 9901 -€18,778 €25,369 +€44,147
Financial income 75/76B €17,939 €504,265 +€486,325 +2,711%
Recurring financial income 75 €17,939 €4,265 -€13,675 -76.2%
Non-recurring financial income 76B - €500,000 +€500,000
Financial charges 65/66B €354,478 €501,449 +€146,971 +41.5%
Recurring financial charges 65 €4,478 €1,449 -€3,029 -67.6%
Non-recurring financial charges 66B €350,000 €500,000 +€150,000 +42.9%
Profit (loss) for the period before taxes 9903 -€355,316 €28,185 +€383,501
Income taxes 67/77 €5,390 €214 -€5,176 -96.0%
Profit (loss) for the period 9904 -€360,706 €27,971 +€388,677
Profit (loss) for the period to be appropriated 9905 -€360,706 €27,971 +€388,677
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.